Blood Cancers Today shared on X:
“Among patients with anemia related to lower-risk MDS, receiving ESAs before transfusions improved outcomes versus after transfusions. Read more about the study presented at EHA2024 by Abdessamia Gandoul, MD, of CHU Grenoble Alpes.” .
Source: Blood Cancers Today/X